Drug Shortage Report for ACT OXYCODONE CR
Report ID | 3381 |
Drug Identification Number | 02394197 |
Brand name | ACT OXYCODONE CR |
Common or Proper name | OXYCODONE |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OXYCODONE HYDROCHLORIDE |
Strength(s) | 20MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2017-03-17 |
Estimated end date | |
Actual end date | 2017-06-30 |
Shortage status | Resolved |
Updated date | 2017-07-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-17 | English | Compare |
v2 | 2017-03-17 | French | Compare |
v3 | 2017-03-18 | English | Compare |
v4 | 2017-05-10 | English | Compare |
v5 | 2017-05-10 | French | Compare |
v6 | 2017-07-01 | English | Compare |
Showing 1 to 6 of 6